36 results on '"Huang, Jialiang"'
Search Results
2. Supplementary Figure 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
3. Supplementary Table 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
4. Supplementary Figure 5 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
5. Supplementary Figure 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
6. Supplementary Figure 3 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
7. Data from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
8. Supplementary Figure Legends from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
9. Supplementary Figure 4 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
10. Supplementary Table 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
11. Supplementary Table 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
12. Data from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
13. Supplementary Figure 3 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
14. Supplementary Figure 5 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
15. Supplementary Figure 1 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
16. Supplementary Figure Legends from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
17. Supplementary Table 2 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
18. Supplementary Figure 4 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
19. Supplementary Table 4 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
20. Supplementary Table 2 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
21. Supplementary Table 1 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
22. Supplementary Table 4 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
23. Supplementary Table 5 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
24. Supplementary Table 5 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
25. Supplementary method from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
26. Supplementary method from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
27. Data from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
28. Supplementary Figures and Legends from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
29. Data from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
30. Supplementary Table 2 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
31. Supplementary Table 3 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
32. Supplementary Table 1 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
33. Supplementary Table 3 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
34. Supplementary Figures and Legends from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
35. PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
36. Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.